Orbimed Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $23.7 Million - $49.4 Million	-848,503 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $9.24 Million - $15.1 Million	-358,383 Reduced 29.69%	848,503 $28.7 Million
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $2.84 Million - $6.36 Million	-73,200 Reduced 5.72%	1,206,886 $49.8 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $22.9 Million - $81.8 Million	661,500 Added 106.94%	1,280,086 $55.5 Million
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $14.2 Million - $24 Million	379,400 Added 158.62%	618,586 $26.5 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $3.03 Million - $13.9 Million	239,186 New	239,186 $11.2 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $394M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.